This is a StreetInsider.com Premium Only Page

(MIRM) –

Apr 23, 2024 04:31 PM Form ARS Mirum Pharmaceuticals, For: Dec 31

Apr 23, 2024 04:22 PM Form DEFA14A Mirum Pharmaceuticals,

Apr 23, 2024 04:20 PM Form DEF 14A Mirum Pharmaceuticals, For: Apr 23

Apr 16, 2024 04:07 PM Stifel Starts Mirum Pharamceuticals (MIRM) at Buy

Apr 16, 2024 04:53 AM Citi Opens 90-Day Upside Catalyst Watch on Mirum Pharamceuticals (MIRM)

Apr 10, 2024 09:30 PM Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Apr 2, 2024 08:33 AM Mirum Pharmaceuticals' (MIRM) LIVMARLI Receives Positive Reimbursement Recommendation by Canada’s CADTH

Apr 2, 2024 08:30 AM Mirum Pharmaceuticals’ LIVMARLI (maralixibat oral solution) Receives Positive Reimbursement Recommendation by Canada’s CADTH for Patients with Cholestatic Pruritus in Alagille Syndrome

Mar 27, 2024 08:48 PM Form 4 Mirum Pharmaceuticals, For: Mar 27 Filed by: BJERKHOLT ERIC

Mar 25, 2024 05:42 PM Form 4 Mirum Pharmaceuticals, For: Mar 25 Filed by: Radovich Peter

Mar 25, 2024 07:00 AM Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors

Mar 18, 2024 05:46 PM Form 4 Mirum Pharmaceuticals, For: Jan 09 Filed by: Radovich Peter

Mar 18, 2024 05:45 PM Form 4 Mirum Pharmaceuticals, For: Jan 09 Filed by: Vig Pamela

Mar 18, 2024 05:40 PM Form 4 Mirum Pharmaceuticals, For: Sep 10 Filed by: Longpre Lara

Mar 18, 2024 05:38 PM Form 4 Mirum Pharmaceuticals, For: Jan 09 Filed by: Peetz Christopher

Mar 18, 2024 05:35 PM Form 4 Mirum Pharmaceuticals, For: Mar 18 Filed by: BJERKHOLT ERIC

Mar 15, 2024 05:35 PM Form S-8 Mirum Pharmaceuticals,

Mar 15, 2024 05:11 PM Form 10-K Mirum Pharmaceuticals, For: Dec 31

Mar 14, 2024 06:32 AM Mirum Pharamceuticals (MIRM) PT Raised to $58 at H.C. Wainwright

Mar 14, 2024 02:40 AM Mirum Pharamceuticals (MIRM) PT Raised to $72 at JMP Securities

Mar 13, 2024 11:45 PM Mirum Pharamceuticals (MIRM) PT Raised to $44 at Leerink Partners

Mar 13, 2024 06:01 PM Mirum Pharmaceuticals (MIRM) Announces FDA Approval of LIVMARLI

Mar 13, 2024 06:00 PM Mirum Pharmaceuticals’ LIVMARLI Receives FDA Approval for Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis

Mar 8, 2024 07:30 PM Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mar 5, 2024 08:00 AM Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences

Mar 4, 2024 06:35 AM Mirum Pharamceuticals (MIRM) PT Raised to $40 at Cantor Fitzgerald

Feb 29, 2024 08:33 AM Mirum Pharmaceuticals (MIRM) Publishes Six-Year Data Demonstrating Improved Clinical Outcomes in Patients with Alagille Syndrome Treated with Mirum’s LIVMARLI

Feb 29, 2024 08:30 AM Hepatology Publishes Six-Year Data Demonstrating Improved Clinical Outcomes in Patients with Alagille Syndrome Treated with Mirum’s LIVMARLI

Feb 29, 2024 03:57 AM Mirum Pharamceuticals (MIRM) PT Raised to $69 at JMP Securities

Feb 28, 2024 05:18 PM Form NT 10-K Mirum Pharmaceuticals, For: Dec 31

Feb 28, 2024 04:44 PM Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 results; offers guidance

Feb 28, 2024 04:06 PM Form 8-K Mirum Pharmaceuticals, For: Feb 28

Feb 28, 2024 04:03 PM Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update

Feb 21, 2024 04:05 PM Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call on February 28, 2024

Feb 14, 2024 12:49 PM Form SC 13G/A Mirum Pharmaceuticals, Filed by: EVENTIDE ASSET MANAGEMENT, LLC

Feb 13, 2024 05:14 PM Form SC 13G Mirum Pharmaceuticals, Filed by: VANGUARD GROUP INC

Feb 9, 2024 09:15 PM Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 5, 2024 09:12 PM Form 4 Mirum Pharmaceuticals, For: Feb 02 Filed by: Vig Pamela

Feb 5, 2024 09:11 PM Form 4 Mirum Pharmaceuticals, For: Feb 02 Filed by: Longpre Lara

Feb 5, 2024 09:06 PM Form 4 Mirum Pharmaceuticals, For: Feb 02 Filed by: Radovich Peter

Feb 5, 2024 09:05 PM Form 4 Mirum Pharmaceuticals, For: Feb 02 Filed by: Peetz Christopher

Feb 5, 2024 07:00 AM NodThera Announces Appointment of Dr. Thomas Jaecklin as Chief Medical Officer

Feb 2, 2024 09:29 PM Form 4 Mirum Pharmaceuticals, For: Jan 31 Filed by: Howe Jolanda

Jan 31, 2024 02:10 PM Form SC 13G Mirum Pharmaceuticals, Filed by: BlackRock Inc.

Jan 25, 2024 07:11 PM Form 4 Mirum Pharmaceuticals, For: Jan 23 Filed by: Longpre Lara

Jan 25, 2024 07:11 PM Form 4 Mirum Pharmaceuticals, For: Jan 23 Filed by: Vig Pamela

Jan 25, 2024 07:11 PM Form 4 Mirum Pharmaceuticals, For: Jan 23 Filed by: BJERKHOLT ERIC

Jan 25, 2024 07:11 PM Form 4 Mirum Pharmaceuticals, For: Jan 23 Filed by: Howe Jolanda

Jan 25, 2024 07:10 PM Form 4 Mirum Pharmaceuticals, For: Jan 23 Filed by: Radovich Peter

Jan 25, 2024 07:10 PM Form 4 Mirum Pharmaceuticals, For: Jan 23 Filed by: Peetz Christopher